FDA’s REMS Drug Safety Program Sometimes Confusing To Patients, And A Barrier To Drug Access: Study
Some patients believe the program is actually set up to benefit drug companies.
Some patients believe the program is actually set up to benefit drug companies.
The program was put in place to prevent cases of neutropenia, which was leaving patients vulnerable to severe and sometimes deadly infections.